30.37
前日終値:
$29.83
開ける:
$29.58
24時間の取引高:
739.72K
Relative Volume:
1.10
時価総額:
$1.42B
収益:
$1.08B
当期純損益:
$-20.76M
株価収益率:
-66.02
EPS:
-0.46
ネットキャッシュフロー:
$151.63M
1週間 パフォーマンス:
+7.58%
1か月 パフォーマンス:
-3.28%
6か月 パフォーマンス:
-34.81%
1年 パフォーマンス:
-6.98%
Omnicell Inc Stock (OMCL) Company Profile
OMCL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
OMCL
Omnicell Inc
|
30.37 | 1.32B | 1.08B | -20.76M | 151.63M | -0.46 |
![]()
VEEV
Veeva Systems Inc
|
279.70 | 37.97B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
TEM
Tempus Ai Inc
|
55.18 | 10.83B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
100.61 | 8.58B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
DOCS
Doximity Inc
|
52.09 | 9.58B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
39.98 | 6.68B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-14 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2024-10-31 | ダウングレード | BofA Securities | Buy → Neutral |
2024-08-02 | アップグレード | Barclays | Underweight → Equal Weight |
2024-01-03 | 開始されました | Barclays | Underweight |
2023-11-03 | ダウングレード | BTIG Research | Buy → Neutral |
2023-11-03 | アップグレード | Piper Sandler | Neutral → Overweight |
2023-11-03 | アップグレード | Wells Fargo | Underweight → Equal Weight |
2023-10-11 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-09-26 | 繰り返されました | Wells Fargo | Underweight |
2023-08-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
2023-07-20 | ダウングレード | Wells Fargo | Overweight → Underweight |
2023-02-27 | アップグレード | The Benchmark Company | Hold → Buy |
2022-11-03 | ダウングレード | The Benchmark Company | Buy → Hold |
2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
2022-09-09 | 開始されました | BofA Securities | Buy |
2022-07-15 | 開始されました | SVB Leerink | Mkt Perform |
2021-12-06 | 再開されました | Wells Fargo | Overweight |
2021-06-09 | 開始されました | JP Morgan | Neutral |
2021-05-24 | 開始されました | BTIG Research | Buy |
2021-02-02 | アップグレード | Piper Sandler | Neutral → Overweight |
2020-12-08 | 開始されました | Berenberg | Buy |
2020-12-03 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2020-07-07 | 開始されました | Stephens | Overweight |
2020-02-07 | 繰り返されました | Dougherty & Company | Buy |
2019-11-21 | 繰り返されました | Dougherty & Company | Buy |
2019-07-26 | アップグレード | Craig Hallum | Hold → Buy |
2019-03-07 | 繰り返されました | Dougherty & Company | Buy |
2018-06-29 | 再開されました | The Benchmark Company | Buy |
2017-09-05 | 繰り返されました | The Benchmark Company | Buy |
2017-07-28 | 繰り返されました | Dougherty & Company | Buy |
2017-04-21 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2017-01-19 | 開始されました | Dougherty & Company | Buy |
2016-12-06 | 繰り返されました | The Benchmark Company | Buy |
2016-07-07 | 繰り返されました | FBR Capital | Outperform |
2016-03-21 | 繰り返されました | Topeka Capital Markets | Buy |
2016-01-07 | 開始されました | The Benchmark Company | Buy |
2015-11-16 | 繰り返されました | Topeka Capital Markets | Buy |
2015-10-30 | 繰り返されました | FBR Capital | Outperform |
2015-09-28 | アップグレード | Sidoti | Neutral → Buy |
2015-07-31 | 繰り返されました | Topeka Capital Markets | Buy |
すべてを表示
Omnicell Inc (OMCL) 最新ニュース
Central Fill Pharmacy Automation Market Top Companies Study -Omnicell, Inc., McKesson Corporation, ScriptPro LLC - openPR.com
Pharmacy Automation Market in 2025-2032 Detailed Study - openPR.com
Opportunities for the Global Medication Management Solutions - openPR.com
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Omnicell stock holds $40 target amid tariff cuts By Investing.com - Investing.com Nigeria
Omnicell stockholders approve equity plan amendment - Investing.com Australia
Omnicell stock rises on prospects of improved profitability due to U.S.-China trade truce, buyback - MSN
Omnicell stockholders approve equity plan amendment By Investing.com - Investing.com Nigeria
Omnicell Stockholders Approve Key Proposals at Annual Meeting - TipRanks
What Analysts Are Saying About Omnicell Stock - Benzinga
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | - GuruFocus
Omnicell (OMCL): Wells Fargo Raises Price Target to $37, Maintains Overweight Rating | OMCL Stock News - GuruFocus
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stoc - GuruFocus
Piper Sandler Adjusts Omnicell Price Target to $57 From $46, Maintains Overweight Rating - marketscreener.com
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback N - GuruFocus
Wells Fargo Boosts Price Target for Omnicell (OMCL) Amid Improved Outlook | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback News | OMCL Stock News - GuruFocus
Omnicell, Inc. authorizes a Buyback Plan. - marketscreener.com
Omnicell Raises Earnings Forecast Amid Lower China Tariffs - Finimize
Omnicell Stock Jumps 5.9% on Strong Profit Guidance and China Tariff CutsNews and Statistics - IndexBox
BofA lifts Omnicell stock price target to $34 from $30 - Investing.com Australia
BofA lifts Omnicell stock price target to $34 from $30 By Investing.com - Investing.com Nigeria
Why Omnicell (OMCL) Stock Is Trading Up Today - Yahoo Finance
Omnicell upgraded at Wells Fargo on positive risk-reward setup - MSN
Omnicell Inc (OMCL) Shares Down 3.27% on May 21 - GuruFocus
Omnicell (OMCL) Adjusts Q2 Revenue and EBITDA Guidance | OMCL St - GuruFocus
Omnicell Updates Q2, 2025 Earnings Guidance, Approves New $75 Million Share Buyback Plan - marketscreener.com
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Pla - GuruFocus
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Plan | OMCL Stock News - GuruFocus
Omnicell (OMCL) Updates FY25 Outlook Amid Tariff Reductions | OM - GuruFocus
Omnicell Updates 2025 Guidance and Stock Buyback Plan - TipRanks
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program - BioSpace
Omnicell Expects Improved Profitability, Updates Second Quarter - GuruFocus
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program | OMCL Stock News - GuruFocus
How the Pharmacy Automation Market Will Evolve by 2032Growth, - openPR.com
Omnicell Surpasses Q1 2025 Revenue Expectations Amidst Future ChallengesNews and Statistics - IndexBox
OMCL Q1 Earnings Call: Revenue Tops Expectations but Tariff Headwinds Pressure Profit Outlook - Yahoo Finance
Omnicell opens innovation lab in Texas - MSN
Omnicell launches RFID products for medication management - Investing.com Australia
Omnicell (OMCL) Unveils New Solutions to Optimize Healthcare Wor - GuruFocus
Omnicell's New Perioperative Clinic Setting Products May Boost Stock - Yahoo Finance
AI companies target Central Texas in latest tech scene shakeup - MySA
Omnicell launches RFID products for medication management By Investing.com - Investing.com Nigeria
3 Hated Stocks Skating on Thin Ice - Yahoo Finance
Omnicell Inc (OMCL) 財務データ
収益
当期純利益
現金流量
EPS
Omnicell Inc (OMCL) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
大文字化:
|
ボリューム (24 時間):